ARCHIVES

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

Study Suggests Biomarker For Resistance to Tamoxifen

March 25, 2011

NCI Get Go-Ahead For New Cancer Control Projects Totaling $7.4 Million, Funded By Grants, Contracts

October 21, 1977

NCI, NINCDS Need Patients For Brain, Breast Studies

September 10, 1982

Funding Opportunities

November 15, 2002

Group Chairmen Approve Policy On Industry Support; NCI Turns Down Request To “Launder” Contributions

December 16, 1983

Conferees Stalled On Money Bill, Running Out Of Time

September 17, 1976